Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826024784?dgcid=rss_sd_all
Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826024784?dgcid=rss_sd_all
“Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial.” European Urology.
@article{article45293,
title = {Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826024784?dgcid=rss_sd_all}
}